ArticleMalaria journal2026
A five-year (2020-2024) malaria surveillance data analysis of Mattu Karl Specialized Comprehensive Hospital, Oromia region, Southwest Ethiopia.
Article in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emerging predominance of Plasmodium vivax and its contribution to severe malaria in Central Ethiopia: a mixed retrospective-prospective study from two tertiary hospitals.BMC infectious diseases · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite significant progress in malaria control, malaria remains a major public health issue in Ethiopia. Regular trend analysis is essential for assessing the effectiveness of interventions.
methodsA retrospective study was conducted from 2020 to 2024 at Mattu Karl Comprehensive Specialized Hospital. Laboratory records of patients tested for malaria were reviewed to assess annual trends and Plasmodium species distribution.
resultsOut of 100,760 patients tested by microscope over the five years, 14,303 (14.2%) were positive for malaria. Plasmodium vivax accounted for 49.1% of cases, Plasmodium falciparum; for 37.8%, and mixed infections for 13.1%. Females represented 51.4% 0f the suspected patients and 51.8% of the confirmed cases. The positivity rate rose from 9.2% in 2020 to 17.7% in 2024.
conclusionMalaria incidence increased over the study period with a concerning rise in mixed infections. The results underscore the need for enhanced malaria control strategies tailored to species dynamics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.